Letter to the Editor in response to the article "Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis"

被引：0
|
作者：
Farag, Youssef M. K. [1 ]
Zheng, Zihe [1 ]
Luo, Wenli [1 ]
机构：
[1] Akebia Therapeut Inc, 245 First St, Cambridge, MA 02142 USA
来源：
PHARMACOLOGICAL RESEARCH | 2021年 / 163卷
关键词：
D O I：
10.1016/j.phrs.2020.105213
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis
    Zheng, Qiyan
    Wang, Yahui
    Yang, Huisheng
    Sun, Luying
    Fu, Xinwen
    Wei, Ruojun
    Liu, Yu Ning
    Liu, Wei Jing
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [32] EFFICACY AND SAFETY OF ETELCALCETIDE IN THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING DIALYSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Vatturi, M.
    Hyderboini, R.
    Veeranki, P.
    Singh, R.
    Inuganti, B.
    Manne, M.
    Dovari, A.
    Chidirala, S.
    Ranjan, A.
    Tanushree, C.
    Goyal, R.
    VALUE IN HEALTH, 2020, 23 : S109 - S110
  • [33] Reply to letter to the editor regarding "Efficacy and safety of finerenone in patients with chronic kidney disease: a systematic review with meta-analysis and trial sequential analysis"
    Fu, Zhangning
    Geng, Xiaodong
    Chi, Kun
    Song, Chengcheng
    Wu, Di
    Liu, Chao
    Hong, Quan
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 11242 - 11243
  • [34] Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis
    Ren, Song
    Zhao, Yurong
    Wu, Jingyu
    Ren, Shangqing
    Feng, Yunlin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] PHOSPHATE BINDERS FOR PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING DIALYSIS: A NETWORK META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
    Hasegawa, Takeshi
    Noma, Hisashi
    Yamada, Shunsuke
    Murashima, Miho
    Nihiwaki, Hiroki
    Mizukami, Aya
    Nishimoto, Masatoshi
    Saito, Hirotaka
    Kimura, Hiroshi
    Taniguchi, Masatomo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I765 - I765
  • [36] Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with chronic kidney disease: meta-analysis of phase 3 randomized controlled trials
    Minutolo, Roberto
    Liberti, Maria Elena
    Simeon, Vittorio
    Sasso, Ferdinando C.
    Borrelli, Silvio
    De Nicola, Luca
    Garofalo, Carlo
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [37] The Efficacy and Safety of Roxadustat for Anemia in Hemodialysis Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials
    Geng, Yunling
    Zhang, Shuaixing
    Cao, Zijing
    Tang, Jingyi
    Cui, Hailan
    Dong, Zhaocheng
    Liu, Yuning
    Liu, Weijing
    TOXICS, 2024, 12 (12)
  • [38] Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on iron regulation in non-dialysis-dependent chronic kidney disease patients with anemia: A systematic review and meta-analysis
    Li, Jing
    Xie, Qiong-Hong
    You, Li
    Xu, Ning-Xin
    Hao, Chuan-Ming
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [39] Response to letter to the editor on "The prevalence and influencing factors of frailty in patients with chronic kidney disease: a systematic review and meta-analysis"
    Li, Bo-Han
    Wu, Guo-Cui
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (04) : 1513 - 1514
  • [40] Response to letter to the editor on “The prevalence and influencing factors of frailty in patients with chronic kidney disease: a systematic review and meta-analysis”
    Bo-Han Li
    Guo-Cui Wu
    International Urology and Nephrology, 2024, 56 : 1513 - 1514
12345